Also found in: Financial.
SPOOSSignificant Payments of Other Sorts (US FDA)
References in periodicals archive ?
5) Significant payments of other sorts (SPOOS), which are payments having a cumulative monetary value of $25,000 or more and are made by any sponsor of a covered study to the investigator or the investigator's institution while the clinical investigator is carrying out the study and for one year following study completion, including payments supporting investigator activities (excluding the costs of conducting the clinical study or other clinical studies) or to provide other reimbursements.
* New Q&A C.6.: Directing the threshold amount for reporting SPOOS is based on the cumulative amount received by the clinical investigator over the course of the study and for one year following its completion, rather than on an annualized basis.